Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
- PMID: 34540704
- PMCID: PMC8448417
- DOI: 10.3389/fonc.2021.760078
Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
Keywords: arteriovenous malformation; hepatocellular carcinoma; oligometastatic; oligoprogressive; stereotactic ablative body radiation; stereotactic body radiotherapy.
Conflict of interest statement
RK: Honoraria from Accuray Inc., Elekta AB, Viewray Inc., Novocure Inc., Elsevier Inc, Brainlab. Institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, Astrazeneca, Exelixis, Viewray Inc, Brainlab. RJ: Honoraria from Cipla Limited. AM: Honoraria from Accuray Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Novel Applications of Stereotactic Body Radiotherapy (SBRT)
Publication types
LinkOut - more resources
Full Text Sources
